Michiya Yokozaki
Hiroshima University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Michiya Yokozaki.
Diagnostic Microbiology and Infectious Disease | 2012
Norifumi Shigemoto; Ryuichi Kuwahara; Shizuo Kayama; Wataru Shimizu; Makoto Onodera; Michiya Yokozaki; Junzo Hisatsune; Fuminori Kato; Hiroki Ohge; Motoyuki Sugai
We identified 5 Klebsiella pneumoniae isolates showing high resistance to β-lactams except imipenem and designated them ISMRK (imipenem-susceptible but meropenem-resistant Klebsiella). They carried the bla(IMP-6) and bla(CTX-M-2) on a self-transmissible plasmid. ISMRK may be falsely categorized as susceptible to carbapenems if imipenem is used to screen carbapenem resistance.
Cancer Letters | 2000
Tetsuya Oguri; Yasuhiro Fujiwara; Osamu Katoh; Haruko Daga; Nobuhisa Ishikawa; Kazunori Fujitaka; Masahiro Yamasaki; Michiya Yokozaki; Takeshi Isobe; Shinichi Ishioka; Michio Yamakido
Abstract We examined the association between the gene expression levels of glutathione S -transferase-π (GST-π) and platinum drug exposure in human lung cancer. First we monitored GST-π gene expression levels in two lung cancer cell lines and in peripheral mononuclear cells of ten previously untreated lung cancer patients after platinum drug exposure. Next we examined GST-π gene expression levels in 40 lung cancer autopsy specimens. The GST-π gene expression levels were assessed by the quantitative reverse transcription–polymerase chain reaction or Northern blot analysis. The GST-π gene expression was not induced by platinum drugs either in vitro and in vivo within 24 h of exposure. In contrast, GST-π gene expression levels in lung cancer tissues of patients who had been exposed to platinum drugs at least 1 month before death were significantly higher than that in those of patients who had not been exposed. These results suggest that GST-π gene expression is associated with chronic exposure to platinum drugs in lung cancer and/or the stress response to xenobiotics.
Journal of Gastroenterology and Hepatology | 2005
Tomohiko Shimatani; Masaki Inoue; Keiko Iwamoto; Hideyuki Hyogo; Michiya Yokozaki; Toshinari Saeki; Susumu Tazuma; Yoko Horikawa
Background: With the prevalence of Helicobacter pylori (H. pylori) infection rapidly decreasing in Japan, endoscopic findings and dyspeptic symptoms need to be re‐evaluated.
Helicobacter | 2005
Tomohiko Shimatani; Masaki Inoue; Keiko Iwamoto; Hideyuki Hyogo; Michiya Yokozaki; Toshinari Saeki; Susumu Tazuma; Yoko Horikawa; Nobue Harada
Background. Follicular gastritis is thought to be caused by Helicobacter pylori infection. However, the pathophysiology of it remains unclear.
Antimicrobial Agents and Chemotherapy | 2015
Shizuo Kayama; Norifumi Shigemoto; Ryuichi Kuwahara; Kenshiro Oshima; Hideki Hirakawa; Junzo Hisatsune; Thomas Jové; Hisaaki Nishio; Katsutoshi Yamasaki; Yasunao Wada; Takeshi Ueshimo; Tetsuya Miura; Taijiro Sueda; Makoto Onodera; Michiya Yokozaki; Masahira Hattori; Hiroki Ohge; Motoyuki Sugai
ABSTRACT We have determined the DNA sequence of Klebsiella pneumoniae multidrug resistance plasmid pKPI-6, which is a self-transmissible IncN-type plasmid. pKPI-6 harboring blaIMP-6 and blaCTX-M-2 confers a stealth-type carbapenem resistance phenotype on members of the family Enterobacteriaceae that is not detectable with imipenem. pKPI-6 is already epidemic in Japan, favoring the dissemination of IMP-6 and CTX-M-2 in members of the family Enterobacteriaceae.
Antimicrobial Agents and Chemotherapy | 2015
Shizuo Kayama; Yumiko Koba; Norifumi Shigemoto; Ryuichi Kuwahara; Tomoko Kakuhama; Kimie Kimura; Junzo Hisatsune; Makoto Onodera; Michiya Yokozaki; Hiroki Ohge; Motoyuki Sugai
The incidence of infections by Enterobacteriaceae carrying the carbapenemase gene showing a paradoxical phenotype of resistance to virtually all s-lactams, including meropenem but not including imipenem, is increasing ([1][1], [2][2], [3][3]). Here we report the first isolation of Klebsiella
Journal of Clinical Microbiology | 2013
Toshie Harino; Shizuo Kayama; Ryuichi Kuwahara; Seiya Kashiyama; Norifumi Shigemoto; Makoto Onodera; Michiya Yokozaki; Hiroki Ohge; Motoyuki Sugai
ABSTRACT Klebsiella pneumoniae showing high resistance to all β-lactams except imipenem, designated as ISMRK (imipenem-susceptible meropenem-resistant Klebsiella) is emerging in Japan. The carbapenem resistance of ISMRK cannot be screened by the Vitek and the RAISUS rapid automated susceptibility test systems, which may lead to inappropriate antimicrobial therapy, resulting in compromised patient outcomes.
Journal of Microbiological Methods | 2012
Shizuo Kayama; Norifumi Shigemoto; Ryuichi Kuwahara; Makoto Onodera; Michiya Yokozaki; Hiroki Ohge; Fuminori Kato; Jyunzo Hisatsune; Motoyuki Sugai
Klebsiella pneumoniae resistant to almost all ß-lactams except imipenem designated as ISMRK (imipenem-susceptible meropenem-resistant Klebsiella) is emerging in Japan. All ISMRK carries bla(IMP-6) which differs from bla(IMP-1) by only a single nucleotide at position 640. We devised a rapid detection system of bla(IMP-6) by using ARMS PCR.
Korean Journal of Laboratory Medicine | 2018
Yumiko Okumura; Toshiki Kajihara; Yumiko Koba; Makoto Onodera; Toshinori Hara; Hiroyuki Tahara; Hideki Ohdan; Hiroki Ohge; Michiya Yokozaki; and Motoyuki Sugai
Yumiko Okumura, B.A., Toshiki Kajihara, M.D., Yumiko Koba, M.S., Makoto Onodera, B.A., Toshinori Hara, M.S., Hiroyuki Tahara, M.D., Hideki Ohdan, M.D., Hiroki Ohge, M.D., Michiya Yokozaki, M.D., and Motoyuki Sugai, D.D.S. Project Research Center for Nosocomial Infectious Diseases, Hiroshima University, Hiroshima, Japan; Division of Infectious Diseases Laboratory, Department of Clinical Practice and Support, Hiroshima University Hospital, Hiroshima, Japan; Division of Laboratory Medicine, Hiroshima University Hospital, Hiroshima, Japan; Department of Infectious Diseases, Hiroshima University Hospital, Hiroshima and Department of Gastroenterological and Transplant Surgery, Hiroshima University, Hiroshima, Japan
Korean Journal of Laboratory Medicine | 2016
Yumiko Joichi; Shizuo Kayama; Ikue Hayashi; Makoto Onodera; Maki Furushimo; Yumiko Koba; Michiya Yokozaki; Hiroki Ohge; Motoyuki Sugai
Yumiko Joichi, A.D., Shizuo Kayama, D.D.S., Ikue Hayashi, Ph.D., Makoto Onodera, B.S.E., Maki Furushimo, A.D., Yumiko Koba, M.S., Michiya Yokozaki, M.D., Hiroki Ohge, M.D., and Motoyuki Sugai, D.D.S. Project Research Center for Nosocomial Infectious Diseases, Hiroshima University; Section of Infection Diseases, Laboratory Division of Clinical Support, Hiroshima University Hospital; Research Facility, Hiroshima University Faculty of Dentistry; Division of Laboratory Medicine, Hiroshima University Hospital; Department of Infectious Diseases, Hiroshima University Hospital, Hiroshima, Japan